Tumor Treating Fields dually activate STING and AIM2 inflammasomes to induce adjuvant immunity in glioblastoma-Reference-Cited by-同舟云学术

Tumor Treating Fields dually activate STING and AIM2 inflammasomes to induce adjuvant immunity in glioblastoma

Published:2022-04-15 Issue:8 Volume:132 Page:
ISSN:1558-8238
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Chen Dongjiang^ORCID,Le Son B.,Hutchinson Tarun E.^ORCID,Calinescu Anda-Alexandra^ORCID,Sebastian Mathew^ORCID,Jin Dan,Liu Tianyi,Ghiaseddin Ashley^ORCID,Rahman Maryam,Tran David D.

Funder

Novocure

NIH/NCI

Florida Department of Health

Florida Center for Brain Tumor Research

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://www.jci.org/articles/view/149258/files/pdf

Reference82 articles.

1. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

2. Brain immunology and immunotherapy in brain tumours

3. Brain Tumor Microenvironment and Host State: Implications for Immunotherapy

4. Turning up the heat on non-immunoreactive tumours: opportunities for clinical development;Ochoa de Olza;Lancet Oncol,2020

5. Alternating electric fields arrest cell proliferation in animal tumor models and human brain tumors

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemically targeting monocytic myeloid-derived suppressor cells using dendrimers and their cell-level biodistribution kinetics;Journal of Controlled Release;2024-10

2. Alternating electric fields transform the intricate network of tumour vasculature into orderly parallel capillaries and enhance the anti‐angiogenesis effect of bevacizumab;Cell Proliferation;2024-08-19

3. Breaking Down Glioma-Microenvironment Crosstalk;The Neuroscientist;2024-07-26

4. Tumor Treating Fields (TTFields) induce homologous recombination deficiency in ovarian cancer cells, thus mitigating drug resistance;Frontiers in Oncology;2024-06-27

5. Effects of tumor treating fields (TTFields) on human mesenchymal stromal cells;Journal of Neuro-Oncology;2024-06-20